News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rainbow BioSciences, LLC JV Target Amarantus BioSciences, Inc. Secures $1.1 Million in Financing


11/15/2012 10:11:39 AM

NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow Biosciences, the biotechnology subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), is pleased to announce that its joint venture target, Amarantus BioSciences (OTCBB: AMBS) has secured over $1.1 million in funding through two separate transactions. In addition to strengthening the company’s balance sheet, financing will go toward funding Amarantus’ ground-breaking new treatments and diagnostics for neurological diseases including Parkinson’s, Traumatic Brain Injury (TBI), Alzheimer’s and more.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES